Skip to main content
OpenTrials
Completed

NCT Number: NCT07298187

The Effect of Head Position on the Optik Nerve Sheath Diameter in Patients During Thyroid Surgery

THE EFFECT OF HEAD POSİTİON ON THE OPTİC NERVE SHEATH DİAMETER İN PATİENTS DURİNG THYROİD SURGERY

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Istanbul University Cerrahpasa

Istanbul, FATİH, 34000, Turkey (Türkiye)

About this study

Aim: In thyroidectomy surgery, the patient's head is placed in hyperextension and the patient is placed in a semi-sitting position to facilitate access to the surgical site. This position of the head causes a decrease in venous return or partial obstruction of venous return due to stretching of the neck veins. The aim of our study is to demonstrate the effect of surgical position on intracranial pressure by measuring the optic nerve sheath diameter (OSSD) using ultrasonography in patients undergoing thyroid surgery and to determine its correlation with post-operative headaches.

Material And Method: Our study was conducted prospectively and randomly in patients undergoing elective total thyroidectomy. Patients aged 18-65 with an ASA score of 1-2 and an operation time of less than 4 hours were included in our study. Patients were positioned in the semi-Fowler position with a 30° extension of the head. Bilateral OSSD surgical positioning was applied, and after ensuring haemodynamic stability for 5 minutes and at the end of the operation, measurements were taken twice using ultrasound, and the average was recorded. The Visual Analogue Scale (VAS) was used to assess postoperative pain intensity. Headache was assessed and recorded at 15 minutes, 30 minutes, 1 hour, 24 hours, 3 days, and 7 days postoperatively.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged between 18 and 65, with an ASA score between 1 and 2 according to the American Society of Anesthesiologists (ASA) physical status classification system
  • whose surgery duration was expected to be less than 4 hours were included in our study.

Exclusion criteria

  • liver failure
  • kidney failure
  • intracranial masses
  • history of hydrocephalus,
  • migraine
  • chronic hypoxemia or hypercarbic lung disease
  • additional heart disease
  • hemodynamic insufficiency
  • neurological and psychiatric diseases,
  • glaucoma
  • patients in whom ocular USG could not provide adequate images
  • patients with pathological problems involving the eyelid and its surrounding area
  • patients with diseases such as periorbital cellulitis
  • patients with preoperative headache complaints
  • patients with known diseases that could cause increased intracranial pressure
  • patients who refused to participate in the study were excluded from the study.

Treatment and study plan

Primary outcomes

  1. OPTİC NERVE SHEATH DİAMETER

    Time frame: INTRAOPERATİVE PERİOD(FROM İNDUCTİON TO THE END OF SURGERY)

    CHANGE İN OPTİC NERVE SHEATH DİAMETER MEASURED BY ULTRASOUND BEFORE AND AFTER POSİTİONİNG DURİNG THYROİDECTOMY

Secondary outcomes

  1. POSTOPERATİVE HEADACHE SEVERİTY (VISUAL ANALOG SCALE)

    Time frame: WİTHİN SEVEN DAYS AFTER SURGERY

    THE SEVERİTY OF POSTOPERATİVE HEADACHE WİLL BE ASSESSED USİNG A VİSUAL ANALOG SCALE. THE LOWEST POSSIBLE SCORE ON THE VISUAL ANALOG SCALE WAS 0, AND THE HIGHEST POSSIBLE SCORE WAS 10.

Sponsors and collaborators

Lead sponsor

Istanbul University - Cerrahpasa

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Dec 23, 2025
Registry last updated
Dec 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.